Coordinatore | TILL I.D. GMBH
Organization address
address: BAHNHOFSTRASSE 89 contact info |
Nazionalità Coordinatore | Germany [DE] |
Totale costo | 2˙338˙267 € |
EC contributo | 1˙580˙100 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2009-single-stage |
Funding Scheme | CP-FP |
Anno di inizio | 2010 |
Periodo (anno-mese-giorno) | 2010-01-01 - 2013-06-30 |
# | ||||
---|---|---|---|---|
1 |
TILL I.D. GMBH
Organization address
address: BAHNHOFSTRASSE 89 contact info |
DE (GRAFELFING) | coordinator | 710˙000.00 |
2 |
TILL PHOTONICS GMBH
Organization address
address: LOCHHAMER SCHLAG 21 contact info |
DE (GRAFELFING) | participant | 303˙100.00 |
3 |
GEMEINSCHAFTSPRAXIS PROF DR MED AXEL NIENDORF DR MED SYLVIA BROCKMOLLER DR MED ANNEGRET DEBUS GBR
Organization address
address: Lornsenstrasse 4 contact info |
DE (Hamburg) | participant | 207˙000.00 |
4 |
STICHTING KATHOLIEKE UNIVERSITEIT
Organization address
address: GEERT GROOTEPLEIN NOORD 9 contact info |
NL (NIJMEGEN) | participant | 199˙600.00 |
5 |
ANDOR TECHNOLOGY PLC
Organization address
address: MILLENNIUM WAY SPRINGVALE 7 contact info |
UK (BELFAST) | participant | 160˙400.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Since the histopathological diagnosis of tumours is based on microscopy, it would be highly desirable to possess a microscopical technique allowing morphological investigation with a wide zoom range, high resolution and the implementation of multiplex staining. Thus, the goal of the REMEDI project is to explore the possibilites of novel light microscopy techniques, which overcome the diffraction limit of visible light and extend the range of observation to the molecular level of proteins in tumour cells and analyze their interaction and spatial distribution. This proposal aims at the use of single-molecule-microscopy of cancer tissue samples with ultra-high sensitivity, simplified handling and increased speed of analysis. This shall be accomplished by the development of a novel resolution-enhanced microscopy platform with an integrated novel CMOS camera and an adequate image acquistion and analysis software. The REMEDI platform will be validated with two relevant applications: diagnostic/experimental pathology of breast cancer and alterations of plasma membrane components of lymphoma cells.'
Rapid, reliable and accurate diagnosis is critical for diseases like cancer. . Medical imaging is an important tool for diagnostics, but conventional light microscopes have stability issues at higher magnifications.